Lensar Inc Reports Results For The Quarter Ended In January 1: Earnings Summary

LENSAR

07/11/2024 20:45

* LENSAR Inc  LNSR.OQ  reported a quarterly adjusted loss
of 13
cents​​ per share for the quarter ended January 1, higher than
the same quarter last year, when the company reported EPS of -23
cents.  The mean expectation of two analysts for the quarter was
for a loss of 29 cents per share. Wall Street expected
results to range from -33 cents to -26 cents per share.
    * Revenue rose 38.2% to $13.54 million from a year ago;
analysts
expected $11.50 million. 
    * LENSAR Inc's reported EPS for the quarter was a loss of 13
cents​.
    * The company reported a quarterly loss of $1.48 million.
    * LENSAR Inc shares had risen by 27.9% this quarter and
gained 67.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is  "buy."

Wall Street's median 12-month price target for LENSAR Inc is
11.00 
This summary was machine generated from LSEG data November 7 at
08:44 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.29          -0.13          Beat
 Jun. 30 2024      -0.29          -0.79          Missed
 Mar. 31 2024      -0.28          -0.19          Beat
 Dec. 31 2023      -0.22          -0.35          Missed